海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Determining the immunological and pain reducing effects of serial radon balneology in patients with musculoskeletal disorders.
- Chronic degenerative spine and/or joint disorders with pain perception of at least 1 year and pain intensity on visual analogue scale =4;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Germany
- 2016-11-11
Authorised
- Medical Treatment of Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Bladder Cancer
- Advanced solid tumors and first-line metastatic squamous NSCLC; first-line metastatic or locally advanced cholangiocarcinoma, gallbladder cancer, or ampullary cancer (biliary tract cancer); and first-line metastatic or locally advanced transitional cell carcinoma (TCC) of the urinary tract (bladder cancer). MedDRA version: 20.0 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10017614 Term: Gallbladder cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Bulgaria, Italy, Poland, Romania, United States
- 2016-10-25
Authorised
- Randomized, multi-center phase II clinical trial for the regeneration of cartilage lesions in the knee using nasal chondrocyte-based tissue (N-TEC) or nasal chondrocyte-based cell- (N-CAM) therapies
- Patients must display 1-2 symptomatic, focal cartilage lesion grade IIIIV (according to the grading by the International Cartilage Repair Society (ICRS)) from 2 to 8 cm2 on the femoral condyle and/or the trochlea, have to be between 18-65 years old and must consent in oral and written manner in order to be enrolled in the study. MedDRA version: 20.0 Level: LLT Classification code 10072638 Term: Articular cartilage defect System Organ Class: 100000004859 ;Therapeutic area: Not possible to specify
- Croatia, Germany, Italy, Switzerland
- 2016-10-04
Authorised
- Treatment with Desferal to improve the impaired reaction to oxygen deficiency in patients with diabetes
- The study will investigate the effect of deferoxamine on the impaired reaction to hypoxia in patients with diabetes mellitus type 1.;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Sweden
- 2016-09-28
Authorised
- Optimization of exercise therapy in type 2 diabetes mellitus.
- Insulin resistance, endothelial dysfunction, cardiovascular fitness, cardio-respiratory responses, glycemic control in deconditioned non-insulin dependent type 2 diabetes patients;Therapeutic area: Body processes [G] - Physiological processes [G07]
- Netherlands
- 2012-08-30
Authorised
- Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies
- to compare the efficacy in the prevention of relapse to manic, depressive, or mixed episodes in two groups of bipolar I patients MedDRA version: 14.1 Level: PT Classification code 10004939 Term: Bipolar I disorder System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Spain
- 2012-03-30
Authorised
- The Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants with Chronic Hepatitis C Infection
- Chronic genotype 1 or genotype 4 Hepatitis C Virus infection MedDRA version: 20.1 Level: LLT Classification code 10047457 Term: Viral hepatitis C System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Germany, Poland, Sweden, United States
- 2017-10-09
Authorised
- Effect of Reslizumab on small airways in asthma. RESSAPEA
- 1. Patients with severe eosinophilic asthma MedDRA version: 20.0 Level: LLT Classification code 10068462 Term: Eosinophilic asthma System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Netherlands
- 2018-06-06
Authorised
- A Phase 2 clinical study evaluating safety and efficacy of EDP-305 in Subjects with Primary Biliary Cholangitis (PBC) without adequate response or intolerance to Ursodeoxycholic Acid (UDCA).
- Primary Biliary Cholangitis (PBC) MedDRA version: 20.1 Level: LLT Classification code 10036680 Term: Primary biliary cirrhosis System Organ Class: 100000004871 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Australia, Austria, Belgium, Canada, France, Germany, Netherlands, Spain, United Kingdom, United States
- 2018-05-24
Authorised
- A Phase 2 clinical study evaluating safety and efficacy of EDP-305 in Subjects with Primary Biliary Cholangitis (PBC) without adequate response or intolerance to Ursodeoxycholic Acid (UDCA).
- Primary Biliary Cholangitis (PBC) MedDRA version: 20.1 Level: LLT Classification code 10036680 Term: Primary biliary cirrhosis System Organ Class: 100000004871 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Australia, Austria, Belgium, Canada, France, Germany, Netherlands, Spain, United Kingdom, United States
- 2018-05-16
Authorised
- A Study with an active treatment to Assess the Long-term Safety of Weekly Intravenous Product in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency
- Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficiency MedDRA version: 20.0 Level: LLT Classification code 10014563 Term: Emphysema pulmonary System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Australia, Canada, Denmark, Estonia, New Zealand, Poland, Sweden, United States
- 2018-02-16
Authorised
- Evaluation de l'intérêt d'un traitement par hydroquinidine pour la prise en charge des patients atteints d'un syndrome de Brugada à risque rythmique élevé et implantés d'un défibrillateur - QUIDAM
- Patients with syndroma of Brugada who have an automatic implantable cardiac defibrillator MedDRA version: 9.1 Level: LLT Classification code 10059027 Term: Brugada syndrome
- France
- 2008-04-07
Authorised
- A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ISIS 301012 as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects
- Reduction of low density lipoprotein C (LDL-C) in Homozygous Familial Hypercholesterolemia (HoFH) MedDRA version: 9.1 Level: LLT Classification code 10057080 Term: Homozygous familial hypercholesterolemia
- United Kingdom
- 2007-03-09
Authorised
- Treatment of anemia in myelodysplastic syndromes low risk with epoetin beta with Analysis of impact on quality of life and functional capacity - GFM-EPO-QoL
- patients with IPSS low- and intermediate-1 risk myelodysplastic syndromes MedDRA version: 12.1 Level: LLT Classification code 10028533 Term: Myelodysplastic syndrome
- France
- 2009-11-19
Authorised
- Effet de différents schémas d'insulinothérapie sur la compliance artérielle, la fonction endothéliale et la fonction autonome cardiaque de patients diabétiques de type 2 mal équilibrés sous traitement antidiabétique oral : étude pilote. - INSUVASC
- Diabéte de type 2 mal équilibré MedDRA version: 8.1 Level: PT Classification code 10012613 Term: Diabetes mellitus non-insulin-dependent
- France
- 2009-10-02
Authorised
- Diabetes and vascular complications: the role of endothelin and physical inactivity’
- type 2 diabetes mellius MedDRA version: 12.0 Level: LLT Classification code 10012613 Term: Diabetes mellitus non-insulin-dependent
- Netherlands
- 2009-08-21
Authorised
- Diabetes mellitus de tipo 2 MedDRA version: 9.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus
- Czech Republic, France, Italy, Netherlands, Poland, Spain, Sweden
- 2008-07-08
Authorised
- Ensayo Clínico aleatorizado para comparar la combinación ZDV + 3TC + ABC (Trizivir) frente a Lopinavir/R (Kaletra) en monoterapia en pacientes con supresión viral en tratamiento previo con ZDV + 3TC + ABC (Trizivir) en la prevención de la aparición de lipoatrofia.
- Pacientes infectados por VIH-1 MedDRA version: 9.1 Level: LLT Classification code 10020445 Term: Human immunodeficiency virus type I infection with constitutional disease
- Spain
- 2008-07-02
Authorised
- A pilot study on the effects of an alternate-day corticosteroid regimen in children with active crohn’s disease - Alternate-day corticosteroid regimen in children with Crohn’s disease
- Crohn's disease MedDRA version: 12. Level: LLT Classification code 10013099 Term: Disease Crohns
- United Kingdom
- 2010-12-08
Authorised
- A Safety and Efficacy Study of CHRONVAC-C followed by Standard Treatment of Hepatitis C infected Patients.
- Treatment of chronic infections caused by hepatitis C virus genotype 1 strains MedDRA version: 13.1 Level: LLT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Sweden
- 2010-11-11
